FDA Approved: NAPROXEN — Supplemental Application (Acella Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Naproxen filed by Acella Pharmaceuticals, LLC, updating the product's approval status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Dysmenorrhea
• Gout
• Juvenile Idiopathic Arthritis
• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• Naproxen (Naproxen)

Snippet

SUPPL AP for NAPROXEN (NAPROXEN)